A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors (Q37166379)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 July 2013
edit
Language Label Description Also known as
English
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
scientific article published on 17 July 2013

    Statements

    A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors (English)
    0 references
    0 references
    0 references
    Ivan Diaz-Padilla
    Hal Hirte
    Amit M Oza
    Brenda Cohen
    Michael Reedjik
    Tong Zhang
    S Percy Ivy
    Sebastien J Hotte
    Albiruni A R Razak
    Eric X Chen
    Irene Brana
    Monika Wizemann
    Lisa Wang
    Lillian L Siu
    17 July 2013
    1182-1191

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit